Post-operative nivolumab significantly improved disease-free survival in resected locally advanced head and neck cancer, ...
More 12,700 people develop the cancers every year with 4,143 dying of the disease but two common drinks could reduce the risk ...
The Head and Neck Radiation Oncology Group (GORTEC) announced significant improvement in disease-free survival for locally ...
Scientists at the University of Utah's Huntsman Cancer Institute analyzed the results of 14 studies by scientists all over the world associated with the International Head and Neck Cancer ...
The US surgeon general cited four studies to back up his new advisory, warning that alcohol is an underappreciated cancer ...
GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol Myers Squibb's anti-PD-1 therapy, as ...